Drug industry to drive speedy growth strategies

Published: 2005-05-03 06:57:00

Updated: 2005-05-03 06:57:00

Most of the drug makers of the fiscal year ending at Mar. 31 announced speedy business growth strategies in the coming fiscal year ensuing the previous year, largely focusing on the so far neglected OTC drug markets.

They achieved a successful business growth in a double digit last year and s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK